GlassScriptPhysician profile
Richard A Okragly
NPI 1265514095
$769.17
in general payments reported to CMS, 2019-2025
13 companies · $22.22 in 2025
The $22.22 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $129 · 2020: $233 · 2021: $201 · 2022: $61.04 · 2023: $98.97 · 2024: $23.67 · 2025: $22.22.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $145.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $144.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $232.11 | 2020-2021 | |
| Djo, LLC | $118.18 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $107.14 | 2020 | |
| Bioventus LLC | $98.97 | 2023 | Durolane |
| Cranial Technologies, INC | $32.16 | 2020-2021 | |
| Novo Nordisk INC | $31.67 | 2021-2022 | |
| Depuy Synthes Sales INC. | $23.67 | 2024 | Monovisc, Orthovisc |
| Bayer Healthcare Pharmaceuticals INC. | $23.20 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $23.17 | 2022 | |
| Pfizer INC. | $22.67 | 2019-2021 | |
| Exact Sciences Corporation | $22.22 | 2025 | Cologuard Collection Kit |
| Abbott Laboratories | $19.62 | 2021 | |
| Jazz Pharmaceuticals INC. | $14.39 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Okragly listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.